Eriksson BI - Search Results

1

Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.

Fisher WD, Eriksson BI, Bauer KA, Borris L, Dahl OE, Gent M, Haas S, Homering M, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG. Fisher WD, et al. Among authors: eriksson bi. Thromb Haemost. 2007 Jun;97(6):931-7. Thromb Haemost. 2007. PMID: 17549294

2

Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.

Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Misselwitz F, Muehlhofer E, Kälebo P. Eriksson BI, et al. Thromb Res. 2007;120(5):685-93. doi: 10.1016/j.thromres.2006.12.025. Epub 2007 Feb 12. Thromb Res. 2007. PMID: 17292948 Clinical Trial.

3

Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement.

Mueck W, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Kälebo P, Muelhofer E, Misselwitz F, Eriksson BI. Mueck W, et al. Among authors: eriksson bi. Thromb Haemost. 2008 Sep;100(3):453-61. Thromb Haemost. 2008. PMID: 18766262 Clinical Trial.

4

A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.

Weitz JI, Cao C, Eriksson BI, Fisher W, Kupfer S, Raskob G, Spaeder J, Turpie AG. Weitz JI, et al. Among authors: eriksson bi. Thromb Haemost. 2010 Dec;104(6):1150-7. doi: 10.1160/TH10-05-0273. Epub 2010 Sep 30. Thromb Haemost. 2010. PMID: 20886185 Clinical Trial.

5

Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.

Turpie AG, Lassen MR, Eriksson BI, Gent M, Berkowitz SD, Misselwitz F, Bandel TJ, Homering M, Westermeier T, Kakkar AK. Turpie AG, et al. Among authors: eriksson bi. Thromb Haemost. 2011 Mar;105(3):444-53. doi: 10.1160/TH10-09-0601. Epub 2010 Dec 6. Thromb Haemost. 2011. PMID: 21136019

6

Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review.

Lee AY, Gent M, Julian JA, Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Lee AY, et al. Among authors: eriksson bi. J Thromb Haemost. 2004 Oct;2(10):1752-9. doi: 10.1111/j.1538-7836.2004.00915.x. J Thromb Haemost. 2004. PMID: 15456486 Free article.

7

Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement.

Eriksson BI, Borris L, Dahl OE, Haas S, Huisman MV, Kakkar AK, Misselwitz F, Kälebo P; ODIXa-HIP Study Investigators. Eriksson BI, et al. J Thromb Haemost. 2006 Jan;4(1):121-8. doi: 10.1111/j.1538-7836.2005.01657.x. J Thromb Haemost. 2006. PMID: 16409461 Free article. Clinical Trial.

8

Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study.

Schellong SM, Beyer J, Kakkar AK, Halbritter K, Eriksson BI, Turpie AG, Misselwitz F, Kälebo P. Schellong SM, et al. Among authors: eriksson bi. J Thromb Haemost. 2007 Jul;5(7):1431-7. doi: 10.1111/j.1538-7836.2007.02570.x. Epub 2007 Apr 6. J Thromb Haemost. 2007. PMID: 17419763 Free article. Clinical Trial.

9

A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.

Eriksson BI, Arfwidsson AC, Frison L, Eriksson UG, Bylock A, Kälebo P, Fager G, Gustafsson D. Eriksson BI, et al. Among authors: eriksson ug. Thromb Haemost. 2002 Feb;87(2):231-7. Thromb Haemost. 2002. PMID: 11858482 Clinical Trial.

10

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.

Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Mouret P, Rosencher N, Eskilson C, Nylander I, Frison L, Ogren M; METHRO III Study Group. Eriksson BI, et al. Thromb Haemost. 2003 Feb;89(2):288-96. Thromb Haemost. 2003. PMID: 12574809 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page